{"version":"1.0","provider_name":"Market Newsdesk","provider_url":"https:\/\/www.marketnewsdesk.com","author_name":"Newsdesk","author_url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/","title":"PTC Therapeutics to Host R&amp;D Day - Market Newsdesk","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"x7GgIbIL0n\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ptc-therapeutics-to-host-rd-day\/\">PTC Therapeutics to Host R&amp;D Day<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.marketnewsdesk.com\/index.php\/ptc-therapeutics-to-host-rd-day\/embed\/#?secret=x7GgIbIL0n\" width=\"600\" height=\"338\" title=\"&#8220;PTC Therapeutics to Host R&amp;D Day&#8221; &#8212; Market Newsdesk\" data-secret=\"x7GgIbIL0n\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.marketnewsdesk.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"PR Newswire Event to take place on Dec. 2, 2025 in New York City WARREN, N.J. , Nov. 20, 2025 \/PRNewswire\/ &#8212; PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it will host an R&amp;D Day to discuss its pipeline on Dec.\u00a02, 2025, at 9:30 a.m. EST in New York City. The event will also be webcast. Matthew B. Klein, M.D., Chief Executive Officer, and PTC research and development team leaders will provide an update on the company&#8217;s proprietary small molecule splicing and inflammation platforms, including new targets and programs. To register for the webcast, please visit the Events and Presentations page on the Investors section of the PTC Therapeutics website at http:\/\/ir.ptcbio.com\/events-presentations. A replay will be available for approximately &hellip; Continue reading \"\"","thumbnail_url":"https:\/\/mma.prnewswire.com\/media\/2582388\/PTC_LOGO_Logo_Logo.jpg"}